The BioMelbourne Network with Seer Pharma present – Corporate Culture & Risk
Successful decision making is strongly influenced by your organisation’s risk culture which is concerned with how you make decisions – and how you allow those around you to make decisions – in the context of change. Companies working in the biotechnology and medical technology sectors all take on risk in order to achieve their business objectives against the backdrop of a constantly changing regulatory and commercial environment.
Building a strong organisational culture is therefore a key part of the approach to risk management, both in terms of preventing ‘bad’ outcomes from happening but also to actively empower the positive risk taking necessary for successful innovation.
This session will explore approaches to tackling risk as an opportunity and how to empower people to make better decisions in the context of a changing healthcare landscape.
Who should attend?
Board directors, CEOs, CFOs and senior decision makers throughout the sector with an interest in organisational culture and risk management.
Date: Tuesday 13th September, 2016
Time: 3:45 registration for 4:00pm – 5:15pm, followed by a networking session
Venue: The Cube, ACMI, Australian Centre for the Moving Image, Federation Square Melbourne, Australia
Speaker: Mr Ken Weldin, Partner, PKF Australia and Q&A session with expert executive panel including:
Kate Costello, Managing Director, Governance Matters
Andrew Batty, Chief Executive Officer, Anatomics
Joanna Johnson – Chief Financial Officer, Company Secretary, IDT Australia
Members – $65
Non-Members – $130
(Prices include GST)
To check if your organisation is a member click here
About our Speakers:
Ken is a Partner in the Audit and Assurance practice of PKF’s Melbourne office. Ken brings an understanding of how complex groups work, the ability to work in and around the Boardroom and C-suite and from that, to cover the technical requirements of your external reporting requirements.
With over 20 year’s professional experience in the UK, US and Australia including time in commercial financial roles in industry, he understands the importance of ‘the Right Information, of the Right Quantity, of the Right Quality and at the Right Time’ in informing corporate decision making and financial reporting outcomes.
Ken holds an MBA where he focused on Corporate Governance and Board Performance and Director Induction matters in particular and is a Fellow of the Governance Institute of Australia (formerly Chartered Secretaries Australia), gaining the leading corporate governance qualification in Australia.
He is a recognised subject matter expert in corporate governance and experienced practitioner in providing tailored governance, risk and compliance solutions in both the public and private sectors, drawing upon learning from his role as lead external auditor to some of Australia’s largest entities.
Ken is a published author on the topic of corporate governance and frequent lecturer on key themes as well as serving on the Governance Institute’s National Legislation Review Committee as an active member of a number of working parties providing comments to regulators and standard setters.
Ken’s recent work has focused on the role of culture and conduct in corporate decision making.
Kate Costello is the Managing Director of Governance Matters, a consulting company specialising in improving corporate governance practices and board performance. The company develops industry-specific governance programs, conducts board performance evaluations and governance reviews and sells governance-related resources. Governance Matters has an office in Bangkok to serve the emerging requirement for independent governance expertise in the South East Asian market.
Kate is also a renowned speaker on governance topics.
Prior to establishing the successful management consultancy, Kate earned a law degree from the University of Melbourne and worked in management at a commercial law firm. She was also an academic at the University of South Australia.
Kate’s experience in the sector stems from over 25 years of work in corporate governance and strategy consulting. She has worked closely with the boards of client organisations across the country and has held several directorships. Kate was also a facilitator in the Company Directors’ Course, a comprehensive director program offered by the Australian Institute of Company Directors.
Internationally, Kate was an integral part in developing an inaugural governance program for Thailand’s Institute of Directors. She was also an alliance group member engaged by AUSAID and the World Bank to undertake a governance initiative in China.
Kate works in governance consulting with boards and executive management on strategy, restructures, reviews, skilling programs and board evaluations. Some notable clients have included:
-Macquarie Bank Ltd
-Department of Defence
-Thailand Institute of Directors
-The Australian Sports Commission (ASC)
-Association of Superannuation Funds of Australia (ASFA)
Kate’s board experience includes directorships of Integrated Research Ltd, Intellitrain Holdings Ltd, The South Australian TAB, Festival City Broadcasters Ltd and Saab Systems Pty Ltd and, chairmanship of Saab ITS and Bassett Consulting Engineers. She currently holds directorships in LBT Innovation Ltd (an ASX listed company), Tech Project Pty Ltd and bzpay Pty Ltd.
Kate chairs accounting firm, Accru Harris Orchard. She was a committee member for the independent review of the governance of soccer in Australia as well as a member of the Independent Selection Committee of the University of Adelaide for 10 years.
Andrew Batty – Chief Executive Officer, Anatomics
Andrew has worked in Sales, Marketing, Business Development, Medical, Clinical Operations and Management with pharmaceutical and biotechnology companies. Following tenures at Roche and GSK Andrew joined CogState, a VC funded UoM start-up and commercialised R&D around neuro-cognitive testing and initiated contracts with Pfizer USA and various research organisations. Andrew then managed Panvax developing immunology-based technologies with the Austin Research Institute before joining IM Medical as CEO. IM Medical, an ASX listed biotechnology company researched and commercialised cardiovascular diagnostic devices for application in a primary care and research setting. In October 2005, Andrew joined Anatomics a medical device manufacturer and developed new products from R&D collaborations, sourced international distributors in 20+ countries and secured manufacturing contracts with Medtronic, Stryker and BBraun. Andrew graduated with a Bachelor of Science and has a Masters of Commerce degree. Andrew is married to Kristi and has four children.
Joanna is a chartered Accountant with many years of senior finance roles in the pharmaceuticals industry. Her first Pharma role was at FH Faulding & Co, progressing to Regional Finance Director, Asia Pacific, with Hospira. Her most recent role was as CFO of Generic Health, a subsidiary of Lupin.
About the Sponsor
SeerPharma are a team of consultants that provide advice, training, software and contract labour resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region on matters of Quality Assurance and GMP compliance. We have been serving our clients in the Asia-Pacific region for over 25 years from our offices in Melbourne, Sydney and Singapore and are also able to provide assistance in Europe through our affiliate in the UK.
We have over 30 consultants who have extensive experience working with clients supplying, or looking to enter the supply chain of a therapeutic product. We work with organizations looking to ensure that their facilities, equipment, quality systems and processes are compliant to bodies such as the FDA, ISO, PIC/S and TGA in which their product(s) are being sold. Our consultants actively train and provide advice to companies on matters of compliance from Research and Development through to Manufacturing, Logistics, Warehousing and Post Market Surveillance. And regularly inspect organisations on behalf of the Australian Government (APVMA) and Pharmaceutical/Medical Device Organisations relying on suppliers in the Asia-Pacific region. Our software team routinely implement electronic Quality management systems to help improve efficiencies for the Quality departments of organisations. Companies also turn to SeerPharma to provide short term Quality Assurance contractors to help with projects that do not warrant hiring a full/part-time employee.
Through our engagement we have made companies in the Asia-Pacific region compliant; up-skilled existing capabilities and improved operational efficiencies. SeerPharma are proud to be known in the market as “Asia-Pacific’s Leader in Quality Assurance and GMP solutions” for the Pharmaceutical and Medical Device Industry.
17 people are attending 13th September – BioBriefing – Corporate Culture and Risk